Immune surveillance of antigen processing pathway
Immune surveillance of antigen processing pathway
批准号:
9287264
负责人:
Nilabh Shastri
金额:
$53.52万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-08 至 2022-02-28
关键词:
AbbreviationsAgeAlpha CellAminopeptidaseAnatomyAntigen ReceptorsAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBiological ProcessCD8-Positive T-LymphocytesCD8B1 geneCell surfaceCellsCharacteristicsComplexCytotoxic T-LymphocytesDefectDevelopmentDifferentiation AntigensEndoplasmic ReticulumEnsureFamilyGenerationsGenesGenetic PolymorphismGlycolipidsGoalsHistocompatibilityHumanI-antigenImmuneImmune EvasionImmune TargetingImmune ToleranceImmune systemImmunizeImmunologic SurveillanceIn VitroKnockout MiceLigandsLinkLocationMalignant NeoplasmsMicrobeMolecularMolecular ChaperonesMonitorMusN-terminalObesityOrthologous GenePathway interactionsPeptide HydrolasesPeptide/MHC ComplexPeptidesPhenotypeProtein IsoformsProteolysisQa-1 AntigenResearchSpecificitySurfaceT-LymphocyteT-Lymphocyte SubsetsTAP1 geneTYRP1 geneTestingThymus GlandTissue GraftsTissuesViralVirusVitaminsWild Type Mousealpha-beta T-Cell Receptorantigen processingantigenic peptide transportercytokineexperienceimprovedin vivoinsightmicrobialnovelpathogenprotein Bresponsesensortumorviral detection
中文摘要
项目总结
英文摘要
Project summary
The long term goal of our research is to understand and manipulate immune surveillance pathways. The
antigen processing pathway yields thousands of peptide/MHC complexes (pMHC I) on the cell surface as
potential ligands for CD8+ T cells to allow detection of viruses or cancer. It is now clear that generation of the
normal pMHC I repertoire requires peptide trimming in the endoplasmic reticulum (ER) by ERAAP, the ER
aminopeptidase associated with antigen processing. The ERAAP is targeted for immune evasion by viruses
and polymorphisms in this gene are linked to many autoimmune diseases. It is therefore essential to monitor
ERAAP activity to ensure effective immune surveillance by CD8+ T cells.
We had discovered earlier that the unique FL9 nona peptide — derived from the Fam49a/b proteins of
unknown function — was presented by the non-classical MHC Ib molecule called Qa-1b only in ERAAP-
deficient cells. This FL9 peptide/Qa-1 complex, called QFL was recognized by QFL-specific CD8+ T cells which
lysed target cells expressing this ligand. Thus QFL- T cells are a mechanism for detecting and eliminating cells
with ERAAP-deficiency. The QFL-T cells are relatively abundant, and share key characteristics with other
innate-like iNKT (invariant NK T) and MAIT (mucosal - associated invariant T) cells which are also restricted by
non-classical MHC Ib molecules and respond to various microbial and self-antigens.
Here we propose to fill gaps in our understanding of how the immune system monitors the fidelity of
antigen processing in the ER. We hypothesize that QFL-specific CD8+ T cells and the mechanisms for
generating the QFL-ligand are conserved sensors for detecting ERAAP-inhibition. Furthermore, disruption of
these mechanisms in ERAAP-deficient mice may result in autoimmune obesity.
We will accomplish these goals by (a) characterizing the αβ TCRs and the thymic developmental pathway
for QFL-T cells to understand how these cells arise and acquire their unique functions, (b) defining the
molecular steps for generating the QFL-ligand by analyzing the processing of Fam49a/b precursors into the
FL9 peptide for loading the Qa-1 MHC Ib, and (c) defining the anatomical location(s) and function(s) of QFL-T
cells in normal WT mice as well as their obese ERAAP-/- counterparts.
Relevance
Autoimmunity results when immune tolerance to self-antigens is disrupted. Understanding how self-antigens
are produced by proteolytic enzymes will likely reveal potential ways to intervene in autoimmune disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unconventional sources of peptides for antigen presentation
-
批准号:9237812
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2017
-
负责人:Nilabh Shastri
-
依托单位:
HLA-peptide repertoire in autoimmunity
-
批准号:8583218
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2013
-
负责人:Nilabh Shastri
-
依托单位:
Immune surveillance via non-classical MHC class Ib molecules
-
批准号:8503599
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2012
-
负责人:Nilabh Shastri
-
依托单位:
Immune surveillance via non-classical MHC class Ib molecules
-
批准号:8358263
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2012
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7173914
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7728304
-
项目类别:
-
资助金额:$37.76万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8235736
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8588887
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8390469
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7008884
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7342495
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:9104281
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8774873
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7895817
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:6850117
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:6784301
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Generating Antigenic Peptide/MHC By Cryptic Translation
-
批准号:7195935
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
GENERATING ANTIGENIC PEPTIDE/MHC BY CRYPTIC TRANSLATION
-
批准号:6697042
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
GENERATING ANTIGENIC PEPTIDE/MHC BY CRYPTIC TRANSLATION
-
批准号:6044315
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
Generating Antigenic Peptide/MHC By Cryptic Translation
-
批准号:7482461
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: